Nasal drug repurposing has seen a real resurgence recently, driven by several factors. From an economic perspective, partners benefit from reduced development costs, intellectual property (IP) creation, increased market share… Read More »
FOR IMMEDIATE RELEASE CONTACT: Carolyn Reis, APR, at Carolyn@ReisCorporatePR.com or (407) 590-0251 ORLANDO, Fla. (February 10, 2020) — Noble International, an industry leader in developing training devices and onboarding solutions… Read More »
Diagnoses of chronic illnesses such as rheumatoid arthritis (RA), Crohn’s disease and osteoporosis are expected to skyrocket in the coming decade, resulting in growing use of patient-centric drug delivery devices… Read More »
In the January 2020 edition of STAT News was a news release from 215 biopharma CEOs and industry leaders. The news release leverages 2020 as the beginning of “the dawn… Read More »
Aptar Pharma, a leading drug delivery systems provider, announces its Platinum Sponsorship of this year’s Drug Delivery to the Lung (DDL) Conference 2019, which takes place from December 11-13 in… Read More »
Crystal Lake, Illinois, October 31, 2019 – AptarGroup, Inc. (NYSE: ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions, announced today that, subsequent to the end… Read More »